Financial News
RenovoRx encountering "a lot of enthusiasm" for innovative cancer platform
June 29, 2023 at 11:42 AM EDT
--News Direct--
RenovoRx Inc (NASDAQ: RNXT) CEO Shaun Bagai speaks to Thomas Warner during a visit to Europe to present at the ESMO World Congress on Gastrointestinal Cancer (ESMO GI) in Barcelona. Bagai gives an overview of the lead candidate product RenovoGem that he has presented to the Congress, before going on to explain where the product is in its development cycle. He says the product has met with "a lot of enthusiasm" so far and reveals his hopes of getting early approval from the FDA "next year or early in 2025."
Contact Details
Proactive United States
Proactive United States
+1 347-449-0879
View source version on newsdirect.com: https://newsdirect.com/news/renovorx-encountering-a-lot-of-enthusiasm-for-innovative-cancer-platform-744883148
More News
View More
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years
Today 11:13 EDT
Tesla’s Earnings Review: Does the Juice Justify the Squeeze?
Today 10:47 EDT
The Top 3 AI-Focused Defense Stocks to Put on Your Radar
Today 10:08 EDT
Recent Quotes
View More
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
